Lawrence Kenyon
Director Financiero/CFO en OUTLOOK THERAPEUTICS, INC. .
Fortuna: 7 748 $ al 30/04/2024
Cargos activos de Lawrence Kenyon
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15/09/2015 | - |
| Director/Miembro de la Junta | 02/08/2018 | - | |
| Director Financiero/CFO | 18/06/2018 | - | |
| Contacto de Relaciones con Inversores | 15/09/2015 | - | |
| Secretario Corporativo | - | - | |
| Treasurer | - | - | |
| Director Ejecutivo | 18/06/2018 | 07/07/2021 | |
| Presidente | 02/08/2018 | 07/07/2021 |
Historial de carrera de Lawrence Kenyon
Antiguos cargos conocidos de Lawrence Kenyon.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARNO THERAPEUTICS, INC. | Director de Operaciones | 18/07/2014 | 01/09/2015 |
| Director Financiero/CFO | 24/02/2014 | 01/09/2015 | |
| Contacto de Relaciones con Inversores | 24/02/2014 | 01/09/2015 | |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Director Ejecutivo | 23/12/2011 | 31/03/2013 |
| Director Financiero/CFO | 23/12/2011 | 18/02/2013 | |
| Presidente | 23/12/2011 | 31/03/2013 | |
| Secretario Corporativo | 23/12/2011 | 31/03/2013 | |
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Director Financiero/CFO | 01/12/2008 | 01/07/2010 |
| PAR PHARMACEUTICAL COMPANIES, INC. | Director Financiero/CFO | 12/12/2008 | 04/06/2010 |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Director/Miembro de la Junta | 01/02/2009 | 01/04/2009 |
| Director de Operaciones | - | - | |
| Director Financiero/CFO | 16/01/2007 | 01/02/2009 | |
| Presidente | - | - | |
| Secretario Corporativo | 16/01/2007 | 01/02/2009 | |
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Director Financiero/CFO | 01/09/2000 | 01/08/2006 |
| Secretario Corporativo | 01/09/2000 | 01/08/2006 |
Formación de Lawrence Kenyon.
| University of Wisconsin | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
Operativa
| Director of Finance/CFO | 7 |
| Corporate Secretary | 4 |
| President | 3 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ARNO THERAPEUTICS, INC. | Health Technology |
| OUTLOOK THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Health Technology |
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Lawrence Kenyon
- Experiencia
